Chordate Medical Holding AB (FRA:K1Z) EPS (Basic) : €-3.28 (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB EPS (Basic)?

Chordate Medical Holding AB's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was €-0.51. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was €-3.28.

Chordate Medical Holding AB's EPS (Diluted) for the three months ended in Sep. 2024 was €-0.51. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €-3.28.

Chordate Medical Holding AB's EPS without NRI for the three months ended in Sep. 2024 was €-0.51. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was -3.28.

During the past 3 years, the average EPS without NRI Growth Rate was 22.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 43.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, Chordate Medical Holding AB's highest 3-Year average EPS without NRI Growth Rate was 63.90% per year. The lowest was -709.80% per year. And the median was 31.70% per year.

Chordate Medical Holding AB EPS (Basic) Historical Data

The historical data trend for Chordate Medical Holding AB's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB EPS (Basic) Chart

Chordate Medical Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-31.05

-10.55

-7.03

-6.22

-4.41

Chordate Medical Holding AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															-0.90	-1.44	-0.88	-0.44	-0.51

Chordate Medical Holding AB EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Chordate Medical Holding AB's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-2.609	-	0)	/	0.591
	=	-4.41

Chordate Medical Holding AB's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.5	-	0)	/	0.980
	=	-0.51

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.28

Chordate Medical Holding AB (FRA:K1Z) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Chordate Medical Holding AB EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordate Medical Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (FRA:K1Z) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

CMH:Sweden

Address

c/o Regus, Kistagangen 20B, Kista, SWE, 164 40

Website

https://www.chordate.com

Chordate Medical Holding AB is a medical technology company that has developed patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel, and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB Headlines

No Headlines